PMA (PMA) Stock Price & Analysis
PMA (PMA) fell 3.10% to USD 1.25 as of September 9, 2026 at 10:12 UTC, according to Nexqual real-time market data.
PMA last closed at USD 1.29; the session ranged USD 1.23–1.3 on volume of 159,927 shares. Market capitalization is $211.22M, with a 52-week range of USD 0.6–3.15 (NCM). Source: Nexqual, September 9, 2026 at 10:12 UTC.
Key Statistics (as of September 9, 2026 at 10:12 UTC)
| Price | USD 1.25 |
|---|---|
| Change | ▼ 3.10% (down) |
| Previous Close | USD 1.29 |
| Open | USD 1.27 |
| Day Range | USD 1.23 – 1.3 |
| 52-Week Range | USD 0.6 – 3.15 |
| Volume | 159,927 shares |
| Market Cap | $211.22M |
| Exchange | NCM |
Technical Analysis (PMA)
Nexqual's technical model rates PMA "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 10:12 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.93 (neutral) |
| vs SMA50 | Below (USD 1.34) |
| MACD | -0.03 (negative) |
Analyst Ratings (PMA)
Wall Street analysts rate PMA "None", per Nexqual as of September 9, 2026 at 10:12 UTC.
| Consensus Rating | None |
|---|
Earnings (PMA)
Source: Nexqual, September 9, 2026 at 10:12 UTC.
Financials & Fundamentals (PMA)
| Total Revenue | $14.63M |
|---|---|
| Revenue Growth (YoY) | -62.30% |
| Gross Margin | -18.39% |
| Operating Margin | -27.88% |
| Profit Margin | -39.40% |
| Current Ratio | 0.71 |
| Total Cash | $1.71M |
| Total Debt | $7.17M |
| Free Cash Flow | $2.77M |
Source: Nexqual, September 9, 2026 at 10:12 UTC.
Financial Health Score (PMA)
Nexqual rates PMA's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 10:12 UTC.
| Growth | Critical — Revenue -62% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $2M cash vs $7M debt |
| Cash Flow | Strong — FCF $3M, 19% margin |
| Efficiency | Mixed — No data |
Ownership (PMA)
| Insider Ownership | +1.34% |
|---|---|
| Institutional Ownership | +0.08% |
| Shares Outstanding | 156.97M |
| Float | 5.28M |
| Short % of Float | +16.83% |
Source: Nexqual, September 9, 2026 at 10:12 UTC.
Leadership (PMA)
PMA is led by Zhijun Pan (age 52), CEO & Non-Independent Chairman of the Board, per Nexqual as of September 9, 2026 at 10:12 UTC.
| CEO & Non-Independent Chairman of the Board | Zhijun Pan (age 52) |
|---|---|
| Chief Financial Officer | To Wa Yiu (age 42) |
Major Backers & Investors (PMA)
Notable institutional backers of PMA include Jane Street Group, LLC, Xtx Topco Ltd, according to Nexqual as of September 9, 2026 at 10:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Jane Street Group, LLC | 0.43% |
| Xtx Topco Ltd | 0.32% |
Source: Nexqual, September 9, 2026 at 10:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRE | Cre8 Enterprise Limited | USD 2.82 | ▼ 1.4% |
| NHP | National Healthcare Properties, | USD 16.49 | ▲ 3.13% |
| LSE | Leishen Energy Holding Co., Ltd | USD 5.06 | ▼ 9.48% |
| RPT | Rithm Property Trust Inc. | USD 12.87 | ▲ 0.39% |
| BFS | Saul Centers, Inc. | USD 32.55 | ▲ 0.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 10:12 UTC. This page is informational and not investment advice.